Published in J Hepatol on November 01, 1992
Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96
Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma. Korean J Physiol Pharmacol (2013) 0.78
Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer (2016) 0.75
Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 4.92
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev (2008) 3.83
Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer (1997) 3.41
Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut (1997) 3.25
Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97
Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors? Am J Gastroenterol (2001) 2.82
Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70
Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol (1996) 2.17
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet (1992) 2.13
Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology (1994) 2.02
Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut (2005) 2.00
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol (1997) 1.97
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol (1997) 1.92
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut (2007) 1.91
The first large population based twin study of coeliac disease. Gut (2002) 1.91
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun (2003) 1.88
Permanent diabetes mellitus in the first year of life. Diabetologia (2002) 1.84
Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol (1993) 1.81
Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol (2004) 1.79
Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun (1996) 1.79
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol (2010) 1.73
Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol (1996) 1.70
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology (1996) 1.61
Capsule enteroscopy in small bowel transplantation. Dig Liver Dis (2003) 1.57
A dose-response effect between a sunlight index and age-related cataracts. Italian-American Cataract Study Group. Ann Epidemiol (1994) 1.55
Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-Hodgkin's lymphoma of bone in adults. Cancer Invest (1998) 1.55
Travel-associated hepatitis A: effect of place of residence and country visited. J Public Health Med (1991) 1.51
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis (2005) 1.49
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut (1999) 1.49
Chordal plication and free edge remodeling for mitral anterior leaflet prolapse repair: 8-year follow-up. Ann Thorac Surg (2001) 1.49
A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol (1997) 1.49
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology (1983) 1.49
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol (2000) 1.48
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ (1994) 1.47
Albumin binding of unconjugated [3H]bilirubin and its uptake by rat liver basolateral plasma membrane vesicles. Biochem J (1996) 1.46
Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol (1994) 1.44
The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol (2001) 1.43
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
Severity of liver disease with different hepatitis C viral clones. Lancet (1991) 1.40
Hormonal treatment of hepatocellular carcinoma. J Hepatol (1991) 1.38
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res (1991) 1.38
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol (1997) 1.35
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
The 1980 earthquake in southern Italy: rescue of trapped victims and mortality. Bull World Health Organ (1983) 1.33
Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) (1982) 1.32
Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther (2008) 1.31
Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr (2006) 1.31
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J (2001) 1.30
Familial clustering of Helicobacter pylori infection: population based study. BMJ (1999) 1.29
Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol (2000) 1.24
Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treat Rep (1979) 1.22
Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol (1996) 1.21
Second-line treatment for primary central nervous system lymphoma. Br J Cancer (1999) 1.21
Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol (1998) 1.20
A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab (2002) 1.19
Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res (1994) 1.16
Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev (2004) 1.15
Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia (2011) 1.15
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br J Cancer (2004) 1.13
Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology (1994) 1.12
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer (1985) 1.12
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol (1994) 1.10
The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol (1994) 1.09
Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line. J Med Virol (1985) 1.09
Characteristics of hepatocellular carcinoma in Italy. J Hepatol (1998) 1.08
New concepts in bilirubin encephalopathy. Eur J Clin Invest (2003) 1.07
Measles epidemiology in Italy. Int J Epidemiol (1984) 1.05
Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J Epidemiol (1988) 1.04
The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol (1992) 1.03
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer (2001) 1.02
Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet (1989) 1.02
Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury. Virus Res (2007) 0.99
Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection (2007) 0.99
Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma. Leuk Lymphoma (1999) 0.99
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. Cancer Invest (2004) 0.99
The Aymara of Western Bolivia. IV. Gene frequencies for eight blood groups and 19 protein and erythrocyte enzyme systems. Am J Hum Genet (1978) 0.99
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol (2005) 0.99
Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metastasis (1992) 0.98
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun (1999) 0.98
Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther (2006) 0.98
Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. Cancer Chemother Pharmacol (2009) 0.97
Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol (1994) 0.97
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie (2007) 0.96
Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol (2001) 0.96
Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol (1990) 0.96
Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96